Chineseinvestors.com, Inc. CIIX Archives - Page 19 of 20

WednesdayMar 29, 2017 11:40 am

ChineseInvestors.com, Inc. (CIIX) Executes a First to Market Milestone

A population of over 1.2 billion people is one heck of a target market, especially when insulated by language. ChineseInvestors.com (OTCQB: CIIX) has leveraged this demographic to market a broad range of products, services and information specifically for the Chinese speaking population. The company provides real-time market commentary, analysis, and education-related services in the Chinese language and offers several types of subscription-based services. Headquartered in Los Angeles with offices in New York City and Shanghai, the company also offers consultation services to private companies seeking to go public, as well as advertising and public relations services. Seizing opportunity, this diverse…

ThursdayMar 23, 2017 3:37 pm

ChineseInvestors.com, Inc. (CIIX) Set to Open California Retail Store, Launches XiBiDi Biotechnology in China

ChineseInvestors.com, Inc. (OTCQB: CIIX) is planning to open a retail store in San Gabriel, California, the same city in which the company is headquartered. The company also recently announced its new online cannabidiol (CBD) oil retail store would be operated by its newly-launched XiBiDi Biotechnology Co., Ltd subsidiary, which is headquartered in the Pudong Free-Trade Area of Shanghai, China. XiBiDi Biotechnology will focus on the online and offline sales of health products, including a range of hemp-derived food and beverages. In a news release, Warren Wang, founder and CEO of CIIX, said he was delighted with the registration and establishment…

ThursdayMar 16, 2017 1:58 pm

ChineseInvestors.com (CIIX) Helping Treat Patients with Amyotrophic Lateral Sclerosis

Late February, a study was released (http://dtn.fm/UEFx3) reviewing evidence that supports the use of cannabinoids to treat Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Also known as Lou Gehrig’s disease, ALS is a fatal illness that attacks the nerve cells that control voluntary muscles such as those in the face, arms, legs, and others. Currently, ALS is treated with riluzole, a drug that controls neuronal signaling, but this drug does not cure the disease and can only slightly increase the chance of survival. With more effective therapeutic options…

TuesdayMar 07, 2017 10:13 am

SeeThruEquity Issues Update on ChineseInvestors.com (CIIX), Increases Price Target to $3.75

Less than two weeks after making a presentation at the SeeThruEquity Conference in Miami Beach, SeeThruEquity increased its price target for ChineseInvestors.com (OTCQB: CIIX) to $3.75. The previous price target for CIIX, issued in October 2016, was $2.05. SeeThruEquity delivers unbiased and unpaid for equity research for publicly traded companies with market capitalizations of less than $1 billion. The increased target price reflects the added potential from legal cannabis initiatives taken by ChineseInvestors.com. Though in the early stages of penetrating the legal cannabis market, ChineseInvestors.com has demonstrated prior success with its profitable investment in Medicine Man Technologies, generating $2.3 million…

WednesdayMar 01, 2017 12:36 pm

ChineseInvestors.com, Inc. (CIIX) Set to Capitalize On Growing Cannabis Industry

Cannabis has been used for thousands of years as a form of natural remedy. But, over time, the possession of marijuana was made illegal in many countries, until now. Most recently, a new movement has taken place whereby both the medical and recreational use of cannabis has been legalized across certain states in the U.S. and a number of countries. The marijuana industry is proving to be important in more ways than one, with Forbes stating that “A new report from New Frontier Data projects that by 2020 the legal cannabis market will create more than a quarter of a…

WednesdayFeb 22, 2017 11:19 am

ChineseInvestors.com, Inc. (CIIX) Taps Traditional Chinese Medicine Market with CBD

No one should have been astonished at the discovery, reported by NPR (http://dtn.fm/ah9NX), of a ‘trove of cannabis plants found in (an) ancient tomb in China’. China represents a past civilization that has sprung many surprises over the centuries, and has given us some of our greatest inventions, including the compass, gunpowder, papermaking, and printing. On par with these innovations has been Traditional Chinese Medicine (TCM), which has relied, in part, on herbal remedies (tui na). The use of plant derivatives to alleviate maladies is as natural to the Chinese as drinking tea, which itself is thought to promote dental…

WednesdayFeb 15, 2017 2:53 pm

SeeThruEquity Report Highlights Recent ChineseInvestors.com, Inc. (CIIX) Investments

A SeeThruEquity report released in February revealed that ChineseInvestors.com, Inc. (OTCQB: CIIX), a specialized investment services company targeting primarily the Chinese-speaking population in the U.S., has made several investments in the global cannabis industry, increasing its growth potential. Still in the early stages of market penetration, the company cited significant potential in its legal cannabis initiatives. Catalysts for potential future growth include a current stake in Medicine Man Technologies, Inc. (OTCQB: MDCL), a business with cultivation, production, and dispensary operations, which has already generated proceeds from stock sales. The company’s recent achievements include completing a $5 million private placement of…

ThursdayFeb 09, 2017 10:12 am

ChineseInvestors.com, Inc. (CIIX) Aiming to Help Tackle Epilepsy with a CBD Oil-Based Pharmaceutical

ChineseInvestors.com, Inc. (OTCQB: CIIX), a company in the business of providing Chinese-speaking investors with real-time market analysis, commentary, and educational services, recently announced its goals for 2017, stating that it plans to develop a CBD oil-based pharmaceutical that could help with the major problem of epilepsy in China. CBD, also known as cannabidiol, is one of the most important healing substances in the hemp plant, helping treat inflammation, convulsions, insomnia, anxiety, ulcers, neuropathic pain, and epilepsy, among other medical problems. The difference between CBD and THC is that THC is classified as a federally controlled psychotropic drug, whereas CBD is…

ThursdayFeb 02, 2017 10:18 am

ChineseInvestors.com, Inc. (CIIX) Revenues Rise For Quarter, Six Months Ended November 30, 2016

ChineseInvestors.com, Inc. (OTCQB: CIIX) filed form 10Q with the SEC on January 23, 2017, stating that it had sharply higher revenues in both the quarter and six months ended November 30, 2016, as compared to the same periods of the prior year. In this filing for its second quarter in fiscal year 2017, it also revised its financials for the year ended May 31, 2016, terming that refiling an immaterial correction. The company reported revenues of $510,944 for the three months ended November 30, 2016. That marked a 133% jump compared to revenues of $219,263 for the same period of…

WednesdayFeb 01, 2017 10:17 am

ChineseInvestors.com, Inc. (CIIX) Discusses Recent Achievements Driving Aggressive Plans for 2017

On Monday, January 30, 2017, Alan Klitenic, the Director of Investor Relations for ChineseInvestors.com, Inc. (OTCQB: CIIX), was interviewed by NetworkNewsWire. Mr. Klitenic described the company, and the growing underserved market it has managed to successfully tap, some of the company’s achievements over the past year, and the aggressive goals it is already pursuing for 2017. Salient points include the following: Description - ChineseInvestors.com, Inc. is a unique financial media service that is tailored to the ethnic Chinese speaking population in the U.S. and Canada. Founded by long-time financial professional Warren Wang, it’s an American company, but with a strong…

Site Search

Company Search

Tag: Chineseinvestors.com, Inc. CIIX